GTBP
GT Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.41
-0.02 ▼ -2.47%
🌙 3월 13일 6:30 PM ET (한국 3/14 07:30)
$0.41
-0.01 ▼ -1.43%
| Index | - | P/E | - | EPS (ttm) | -14.62 | Insider Own | 12.92% | Shs Outstand | 0.03B | Perf Week | -11.68% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 18.75% | Insider Trans | - | Shs Float | 0.03B | Perf Month | -12% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.08 | Inst Own | 2.01% | Short Float | 7.6% | Perf Quarter | -38.36% |
| Income | -0.06B | P/S | - | EPS this Y | 95.21% | Inst Trans | 0.51% | Short Ratio | 1.32 | Perf Half Y | -44.36% |
| Sales | 0.00B | P/B | 1.83 | EPS next 5Y | 67.95% | ROA | -740.43% | Short Interest | 2.09M | Perf YTD | -47.21% |
| Book/sh | 0.23 | P/C | 1.89 | EPS past 3/5Y | 31.76% 49.68% | ROE | -2218.95% | 52W High | -89.23% ($3.85) | Perf Year | -83.29% |
| Cash/sh | 0.22 | P/FCF | - | Sales past 3/5Y | - | ROIC | -964.75% | 52W Low | 5.87% ($0.39) | Perf 3Y | -97.67% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -108.12% | Gross Margin | - | Volatility(W/M) | 9.31% 10.07% | Perf 5Y | -99.77% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 3.22 | EPS Q/Q | -161.19% | Profit Margin | - | RSI (14) | 36.02 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.22 | Sales Q/Q | - | SMA20 | -8.73% ($0.45) | Beta | 1.19 | Target Price | $3 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -28.07% ($0.57) | Rel Volume | 0.35 | Prev Close | $0.43 |
| Employees | 1 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -909.09% - | SMA200 | -65.18% ($1.18) | Avg Volume(3M) | 1.58M | Price | $0.41 |
| IPO | 1980/3/17 | Option/Short | No/Yes | Trades | 1050 | Volume | 549,092 | Change | -2.47% |
뉴스 로딩 중...